Solid Phase Peptide Cleavage Using Trifluoroacetic Acid and 1,2-Ethanedithiol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for solid phase peptide synthesis, particularly for GLP-1 agonists, face challenges in achieving high peptide yield due to incomplete cleavage and residual side chain protection group removal, leading to inefficiencies and increased costs.
Innovation Solution
A method involving a composition of trifluoroacetic acid and 1,2-ethanedithiol at elevated temperatures, reducing the number of reagent components, and omitting a second cleavage step to enhance peptide yield and simplify the production process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing methods for solid phase peptide synthesis are used, then peptide synthesis can be performed, but peptide yield is low due to incomplete cleavage and residual side chain protection group removal
Solution Approach 1:
The patent changes the chemical composition parameters of the cleavage cocktail by replacing traditional scavengers (water, thioanisole, phenol, triisopropylsilane) with 1,2-ethanedithiol at a specific concentration range (1-5% v/v), and adjusts the trifluoroacetic acid content to 95-99% v/v. This parameter optimization achieves both complete cleavage and effective side chain protection group removal, resolving the contradiction between productivity and reliability.
Solution Approach 2:
The patent introduces 1,2-ethanedithiol as an intermediary substance that mediates the cleavage reaction. This compound acts as a scavenger that preferentially reacts with side chain protection groups, preventing their unwanted attachment to the peptide while facilitating complete cleavage from the solid phase. The intermediary substance resolves the contradiction by selectively managing different reaction pathways.
2Reliability
If multiple reagent components are used for cleavage, then side chain protection groups can be removed, but the production process becomes complex and costly
Solution Approach 1:
The patent extracts and eliminates unnecessary reagent components from the traditional cleavage cocktail. By removing water, thioanisole, phenol, and triisopropylsilane, and retaining only trifluoroacetic acid and 1,2-ethanedithiol, the formulation is simplified while maintaining effective side chain protection group removal. This extraction principle reduces production process complexity without compromising reliability.
Solution Approach 2:
The patent makes the cleavage cocktail universal by designing a simplified formulation that performs multiple functions: cleaving the peptide from the solid phase and removing side chain protection groups. The combination of trifluoroacetic acid and 1,2-ethanedithiol achieves both functions simultaneously, eliminating the need for separate steps or additional reagents, thus reducing process complexity while maintaining reliability.
3Productivity
If multiple cleavage steps are performed, then peptide yield can be improved, but handling and process time increase
Solution Approach 1:
The patent merges the cleavage function and side chain protection group removal function into a single integrated step. The optimized cleavage cocktail containing trifluoroacetic acid and 1,2-ethanedithiol performs both functions simultaneously during one contact period, eliminating the need for sequential cleavage steps. This merging achieves high peptide yield while reducing process time and simplifying handling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases peptide yield by 5%, reduces costs, improves analytical quality control, and simplifies handling, while maintaining a favorable impurity profile.
Implementation Method 1
contacting the solid phase, to which the polypeptide is bound, with a composition consisting essentially of trifluoroacetic acid and 1,2-ethanedithiol
Data Source
AI summary
The invention relates to a method for the cleavage of a solid phase-bound polypeptide from the solid phase, the method comprising contacting the solid phase, to which the polypeptide is bound, with a composition consisting essentially of trifluoroacetic acid and 1,2-ethanedithiol, at a temperature in the range of about 23° C. to about 29° C.